Advancements in Nanoparticle-Based Therapies for Breast Cancer: Current Trends and Future Prospects. [PDF]
Matalqah SM +6 more
europepmc +1 more source
Case report: PD-L1-targeted high-affinity natural killer cells and IL-15 superagonist N-803-based therapy extend overall survival of advanced metastatic pancreatic cancer patients. [PDF]
Seery T +6 more
europepmc +1 more source
Equipoise lost in pancreatic cancer: reimagining crossover for promising cancer therapies. [PDF]
Vora KB, Bates SE.
europepmc +1 more source
Nanotechnology-Driven Cancer Therapies for Precision Oncology: Advances and Clinical Outlook. [PDF]
Gupta V +10 more
europepmc +1 more source
Hype vs. Health: How Approved Nanomedicines Have Met (or Missed) Early Predictions. [PDF]
Fröhlich E.
europepmc +1 more source
Collagen Signaling via DDR1 Exacerbates Barriers to Macromolecular Drug Delivery in a 3D Model of Pancreatic Cancer Fibrosis. [PDF]
Ohira M +14 more
europepmc +1 more source
Decoding the Integrated Stress Response of Pancreatic Cancer: Identifying a Serine-dependent Tumor Subset Under Metabolic Relationships With CAFs. [PDF]
Shin S +25 more
europepmc +1 more source
Prognostic Implications of Codon-Specific <i>KRAS</i> Mutations in Localized and Advanced Stages of Pancreatic Cancer. [PDF]
Raji S +13 more
europepmc +1 more source
Research progress on precision targeted therapy strategies for breast cancer based on tumor microenvironment. [PDF]
Luo Y, Xie P, Yang S, Qu P, Hou L, Yi Q.
europepmc +1 more source
Polymeric Therapeutic Nanosystems Containing Paclitaxel: Novel Strategies, Therapeutic Potential, Challenges, and Translation Problems. [PDF]
Sobczak M, Kędra K.
europepmc +1 more source

